Description
Composition and action of Budecort Inhaler 200 MD 100 mcg Cipla, profile of the main ingredient
Budecort Inhaler 200 MD 100 mcg Cipla is a leading inhalation aerosol primarily used for the management of respiratory conditions. Its primary active ingredient is Budesonide, a potent corticosteroid known for its anti-inflammatory properties. The inhaler is formulated to deliver precise dosages directly to the lungs, maximizing therapeutic effects while minimizing systemic absorption.
The composition includes:
- Budesonide 100 mcg per actuation
- Propellant: Hydrofluoroalkane (HFA) 134a
- Other excipients for stability and effectiveness
Budesonide functions by targeting inflammation in the airways, reducing swelling, and enhancing airflow. This action can be particularly beneficial for athletes, as controlled respiration is essential during intense training sessions.
Effectiveness in training, muscle adaptation and energy
Budesonide, the active component in Budecort Inhaler, plays a crucial role in enhancing overall athletic performance. By minimizing airway inflammation, athletes can experience improved oxygen flow during physical exertion, leading to better endurance and performance.
In terms of muscle adaptation, reduced respiratory distress allows for longer and more effective training sessions, thereby facilitating muscle growth and adaptation. The inhaler can be an essential tool for those with exercise-induced bronchoconstriction, ensuring that respiratory issues do not hinder workout intensity.
Additionally, efficient oxygen utilization directly correlates with energy levels, making it easier for individuals engaged in high-intensity training to maintain stamina. Consequently, proper use of Budecort Inhaler can help athletes achieve optimal performance and derive maximum benefits from their training regimens.
How to get Budecort Inhaler 200 MD 100 mcg Cipla online, advantages of our store
Obtaining Budecort Inhaler 200 MD 100 mcg Cipla online has never been easier. Many reputable pharmacies provide convenient access to this medication, ensuring customers can maintain their training without interruption.
When purchasing from our store, you enjoy several advantages:
- Competitive pricing on all products
- Fast and discreet shipping
- Reliable customer service to assist with inquiries
- Secure payment options ensuring user safety
By choosing our online pharmacy, customers can rest assured they are receiving genuine products while enjoying the ease of home delivery.
Optimal cycle duration, when to start and stop
For effective results, it is recommended to use Budecort Inhaler 200 MD 100 mcg Cipla as part of a well-structured plan. Typically, users should consider cycles that last between four to six weeks. Starting the inhaler before rigorous training, particularly for those prone to respiratory issues, can optimize its benefits.
It is advisable to start using Budecort at least one week before a significant training period or competition to allow the medication to take effect. Conversely, stopping should be gradual and under professional guidance to avoid potential withdrawal symptoms or complications, particularly in sensitive individuals.
Possible adverse effects, important precautions
Despite its benefits, Budecort Inhaler 200 MD 100 mcg Cipla can cause some side effects. Understanding these is crucial for safe usage. Potential adverse effects may include:
- Throat irritation or hoarseness
- Coughing or wheezing
- Headaches
- Risk of oral thrush
It is vital to consult a healthcare professional before starting any new medication to assess individual respiratory health and potential interactions with other medications. Regular monitoring is equally important to identify any adverse effects early and adjust the dosage if necessary. Proper usage and adherence to medical advice ensure that athletes can safely take advantage of the benefits provided by Budecort Inhaler, enhancing their training efficiency and overall performance.
Additional information
| Active substance | Budesonide |
|---|---|
| Water Retention | Minimal |
| Hepatotoxicity | Low |
| Lab Test | Not specific for standard drug tests |
| Strength | 100mcg |
| Also known as | Budesonidum |
| Blood pressure | Typically no effect on blood pressure |
| Trade name | Pulmicort, Rhinocort |
| Storage conditions | Store in a cool, dry place away from direct sunlight |
| Chemical name | (RS)-11ОІ,16О±,17,21-Tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16,17-acetal with butyraldehyde |
| Formula | C25H34O6 |
| Substance class | Corticosteroid |
| Main action | Anti-inflammatory |
| Half-life | 2 to 3.6 hours |
| Dosage (medical) | Inhalation (100 to 800 micrograms per day), Oral (9 mg per day), Nasal spray (256 micrograms per day) |
| Dosage (sports) | Not applicable |
| Effects | Reduces inflammation, suppresses immune response |
| Side effects | Oral thrush, hoarseness, cough, headache, nausea, adrenal suppression |
| Use in sports | Not commonly used, except for legitimate asthma treatment |
| Manufacturer | Cipla Ltd. |
| Packing | 1 Inhaler/pack |
Related products
-

Seretide Disckus (Advair) 250 mcg Glaxosmithkline
0 out of 5€75.00 Add to basket -

Rovamycine 3.000.000 iu Eczacibasi
0 out of 5€42.00 Add to basket -

Norvacs 5 mg Pfizer
0 out of 5€24.00 Add to basket -

Dihydroboldos 100 mg Driada Medical
0 out of 5€0.00 Select options This product has multiple variants. The options may be chosen on the product page





Reviews
There are no reviews yet.